news

Congressman Bob Latta (R-Bowling Green) voted in favor of a bill that would mandate the Department of Health and Human Services (HHS) to have working verification systems in place to validate eligibility of applicants who are applying for the health care exchange subsidies. Latta cosponsored H.R. 2775, the No Subsidies Without Verification Act, which passed the House today. “In spite of… Read more »

Congressman Bob Latta (R-Bowling Green) issued the following statement regarding the Obama administration's decision to delay the ObamaCare employer mandate by one year:   "The decision made today by the Obama Administration to delay implementation of a part of its own law only reiterates what House Republicans have been saying for the past three years, that this massive government… Read more »

Today, the U.S. House of Representatives passed H.R. 1919, the Safeguarding America's Pharmaceuticals Act of 2013, a bipartisan bill sponsored by Congressman Bob Latta (R-OH) to strengthen and secure the nation’s pharmaceutical distribution supply chain. Co-authored by Rep. Jim Matheson (D-UT), this legislation is a result of collaboration and input from stakeholders throughout the… Read more »

Congressman Bob Latta (R-Bowling Green) today voted in favor of repealing the Patient Protection and Affordable Care Act (PPACA), also known as ObamaCare. Latta issued the following statement after the bill passed on the House Floor this afternoon: “With promises of providing health care that is more affordable and widely available, ObamaCare has proved to do just the opposite. I… Read more »

The House Energy and Commerce Committee today approved legislation introduced by Congressman Bob Latta (R-OH) that will strengthen and secure the nation’s pharmaceutical distribution supply chain. The Committee, chaired by Rep. Fred Upton (R-MI), approved H.R. 1919, the Safeguarding America's Pharmaceuticals Act of 2013 by a voice vote. “The pharmaceutical supply chain touches every part… Read more »

Today, Congressman Bob Latta (R-Bowling Green) introduced H.R.1919, Safeguarding America's Pharmaceuticals Act of 2013, a bipartisan bill to strengthen and secure our nation’s pharmaceutical distribution supply chain to protect American families against counterfeit pharmaceuticals. This legislation is a result of collaboration and input from stakeholders throughout the pharmaceutical… Read more »

Congressman Bob Latta (R-Bowling Green) today issued the following statement on the three-year anniversary of the passage of the Patient Protection and Affordable Care Act, otherwise known as Obamacare: “Throughout the health care debate we repeatedly heard promises of reduced health care costs, increased accessibility, and job creation, but three years since Obamacare was signed into… Read more »

A joint, bicameral report released by Congressional Republicans estimates an increase in health care premiums for some Americans, specifically young adults and the middle class, when major provisions of President Obama’s health care law go into effect next year. Analysis from the report projects an increase in Ohio health care premiums between 55 to 106 percent. “During the health care… Read more »

A joint, bicameral report released this week by Congressional Republicans outlines estimated increases in health care premiums for some Americans, specifically young adults and the middle class, when major provisions of President Obama’s health care law go into effect next year. Analysis from the report projects an increase in Ohio health care premiums between 55 to 106 percent. The… Read more »

With the start of the new year, one of the little noticed but potentially harmful features of Obamacare has now gone into effect. It is the tax on medical device manufacturers. The new tax of 2.3 percent is placed on the revenues of companies that produce medical devices such as heart valves, insulin pumps and hundreds of thousands of carefully engineered and regularly improved… Read more »